"the share price movement going to be always on hindsight TypeC...

"the share price movement going to be always on hindsight TypeC meet, query fulfillment, Phase 3 approval, recruitment and completion should get it to over a dollar in next 9 months"

If you look at the Type C meeting request announcement, they state if the meeting goes well they hope to get Phase 3 trial approval early in 2023. After FDA approval they'll then have to set up to start the trial. You're looking at ~9 months before the phase 3 trial even starts recruitment. And based on their Phase 2 trial timelines, it's likely phase 3 will follow a similar timeline of 3-4 years. All of that information is on the website. 9 months to tick off everything you listed is literally impossible based on the info the company has provided.

When TRP listed publicly they anticipated phase 3 trials would have started recruiting in 2H 2022. Since then they've been almost entirely silent of any program updates aside from the Type C request and a revised "trial approval" estimate of early 2023. They provided no explanation of why there's been so many delays to their progress. The management team needs to work on their investor relation skills. If they keep this up, the SP will continue to languish below 50c until mid-year 2023 when the trial will presumably start.